Assessment of safety and tolerability of remogliflozin etabonate (GSK189075) when administered with total daily dose of 2000 mg of metformin

Assessment of safety and tolerability of remogliflozin etabonate (GSK189075) when administered with total daily dose of 2000 mg of metformin

Abstract Background Patients with type 2 diabetes mellitus (T2DM) are characterized by an elevated glycemic index and are at a higher risk for complications such as cardiovascular disease, nephropathy, retinopathy and peripheral neuropathy. Normalization of glycemic index can be achieved by dosing c...

Full description

Saved in:
Bibliographic Details
Main Authors: Robert Dobbins (Author), Elizabeth K. Hussey (Author), Robin O'Connor-Semmes (Author), Susan Andrews (Author), Wenli Tao (Author), William O. Wilkison (Author), Bentley Cheatham (Author), Katare Sagar (Author), Barkate Hanmant (Author)
Format: Book
Published: BMC, 2021-06-01T00:00:00Z.
Subjects:
article
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available

Similar Items